. Who and . Unaids, Global summary of the AIDS epidemic, 2012.

G. Arage, G. A. Tessema, and H. Kassa, Adherence to antiretroviral therapy and its associated factors among children at South Wollo Zone Hospitals, Northeast Ethiopia: a cross-sectional study, 2014.

, WHO. Global update on HIV treatment 2013: results and opportunities, 2015.

M. Penazzato, P. Revill, A. J. Prendergast, I. J. Collins, S. Walker et al., Early infant diagnosis of HIV infection in low-income and middle-income countries: does one size fit all?, Lancet Infect Dis, vol.14, issue.7, pp.650-655, 2014.

A. L. Ciaranello, Y. Chang, A. V. Margulis, A. Bernstein, I. V. Bassett et al., Effectiveness of pediatric antiretroviral therapy in resourcelimited settings:a systematic review and meta-analysis, Clin Infect Dis, vol.49, pp.1915-1942, 2009.

S. P. Rojas and A. Holguin, Drug resistance in the HIV-1-infected paediatric population worldwide:a systematic review, J Antimicrob Chemother, vol.69, pp.2032-2074, 2014.

P. R. Mutwa, K. R. Boer, J. Rusine, N. Muganga, D. Tuyishimire et al., Long-term effectiveness of combination antiretroviral therapy and prevalence of HIV drug resistance in HIV-1-infected children and adolescents in Rwanda, Pediatr Infect Dis, vol.33, pp.63-72, 2014.

T. D. Ruel, M. R. Kamya, P. Li, W. Pasutti, E. D. Charlebois et al., Early virologic failure and the development of antiretroviral drug resistance mutations in HIV-infected Ugandan children, J Acquir Immune Defic Syndr, vol.56, pp.44-50, 2011.

C. Nchads and . Chhorvann, Saphonn Vonthanak Estimations and Projections of HIV/AIDS in Cambodia, 2010.

, Conceptual Framework for Elimination of New HIV infections in Cambodia by 2020, 2011.

, NCHADS. Fourth quaterly report, 2012.

, NCHADS. Annual report, 2013.

B. Janssens, B. Raleigh, S. Soeung, K. Akao, V. Te et al., Effectiveness of highly active antiretroviral therapy in HIV-positive children:evaluation at 12 months in a routine program in Cambodia, Pediatrics, vol.120, pp.1134-1174, 2007.
URL : https://hal.archives-ouvertes.fr/pasteur-00599045

P. Isaakidis, M. E. Raguenaud, V. Te, C. S. Tray, K. Akao et al., High survival and treatment success sustained after two and three years of first-line ART for children in Cambodia, J Int AIDS Soc, 2010.

M. E. Raguenaud, P. Isaakidis, R. Zachariah, V. Te, S. Soeung et al., Excellent outcomes among HIV + children on ART, but unacceptably high pre-ART mortality and losses to follow-up:a cohort study from Cambodia, BMC Pediatr, 2009.

B. P. Westley, A. K. Delong, C. S. Tray, D. Sophearin, E. M. Dufort et al., Prediction of treatment failure using 2010 World Health Organization Guidelines is associated with high misclassification rates and drug resistance among HIV-infected Cambodian children, Clin Infect Dis, vol.55, pp.432-472, 2012.

J. Nouhin, Y. Madec, N. Ngo-giang-huong, L. Ferradini, and E. Nerrienet, Increased Risk of Q151 M and K65R Mutations in Patients Failing Stavudine-Containing First-line Antiretroviral Therapy in Cambodia, PLoS One, vol.8, p.73744, 2013.

M. Coetzer, B. Westley, A. Delong, C. Tray, D. Sophearin et al., Extensive drug resistance in HIV-infected Cambodian children who are undetected as failing first-line antiretroviral therapy by WHO 2010 guidelines, AIDS Res Hum Retroviruses, vol.29, pp.985-92, 2013.

, National Center for HIV/AIDS DaSTDN National guidelines for the use of pediatric antiretroviral therapy in Cambodia, 2011.

H. Barennes, S. Tat, D. Reinharz, and U. Vibol, Perceived stigma by children on antiretroviral treatmentin Cambodia, BMC Pediatr, 2014.

, WHO Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection, 2013.

, WHO Antiretroviral therapy for HIV infection in infants and children:recommendations for a public health approach, 2010.

O. Segeral, S. Limsreng, J. Nouhin, C. Hak, S. Ngin et al., Three years follow-up of first-line antiretroviral therapy in cambodia:negative impact of prior antiretroviral treatment, AIDS Res Hum Retroviruses, vol.27, pp.597-603, 2011.
URL : https://hal.archives-ouvertes.fr/pasteur-00599248

S. Sophan, C. Y. Meng, P. Pean, J. Harwell, E. Hutton et al., Virologic and immunologic outcomes in HIV-infected Cambodian children after 18 months of highly active antiretroviral therapy, Southeast Asian J Trop Med Public Health, vol.41, pp.126-163, 2010.

L. Ferradini, D. Laureillard, N. Prak, C. Ngeth, M. Fernandez et al., Positive outcomes of HAART at 24 months in HIV-infected patients in Cambodia, AIDS, vol.21, pp.2293-301, 2007.

L. Ferradini, V. Ouk, O. Segeral, J. Nouhin, A. Dulioust et al., High efficacy of lopinavir/r-based second-line antiretroviral treatment after 24 months of follow up at ESTHER/Calmette Hospital in Phnom Penh, Cambodia. J Int AIDS Soc, vol.14, p.14, 2011.
URL : https://hal.archives-ouvertes.fr/pasteur-00598973

G. Morineau, M. C. Vun, H. Barennes, R. C. Wolf, N. Song et al., Survival and quality of life among HIV-positive people on antiretroviral therapy in Cambodia, AIDS Patient Care STDS, vol.23, pp.669-77, 2009.

M. Pujades-rodriguez, B. Schramm, L. Som, E. Nerrienet, P. Narom et al., Immunovirological outcomes and resistance patterns at 4 years of antiretroviral therapy use in HIV-infected patients in Cambodia, Trop Med Int Health, vol.16, pp.205-218, 2011.

M. Zolfo, J. M. Schapiro, V. Phan, O. Koole, S. Thai et al., Genotypic impact of prolonged detectable HIV type 1 RNA viral load after HAART failure in a CRF01_AE-infected cohort, AIDS Res Hum Retroviruses, vol.27, pp.727-762, 2011.

S. Biressaw, W. E. Abegaz, M. Abebe, W. A. Taye, and M. Belay, Adherence to Antiretroviral Therapy and associated factors among HIV infected children in Ethiopia: unannounced home-based pill count versus caregivers' report, BMC Pediatr, vol.13, p.132, 2013.

K. Kikuchi, K. C. Poudel, J. Muganda, A. Majyambere, K. Otsuka et al., High risk of ART non-adherence and delay of ART initiation among HIV positive double orphans in Kigali, Rwanda. PLoS One, vol.7, p.41998, 2012.

L. M. Franco, B. Burkhalter, W. A. De, L. Jennings, A. G. Kelley et al., Evidence base for children affected by HIV and AIDS in low prevalence and concentrated epidemic countries: applicability to programming guidance from high prevalence countries, AIDS Care, vol.21, issue.1, pp.49-59, 2009.